Euroopan unioni - norja - EMA (European Medicines Agency)

acorda therapeutics ireland limited - levodopa - parkinsonsykdom - anti-parkinson medisiner - inbrija er indikert for intermitterende behandling av episodisk motoriske fluktuasjoner (av episoder) hos voksne pasienter med parkinsons sykdom (pd) behandlet med levodopa/dopa-decarboxylase inhibitor.

Euroopan unioni - norja - EMA (European Medicines Agency)

ecuphar nv - enflicoxib - antiinflammatoriske og antirheumatiske produkter - hunder - for the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.

Euroopan unioni - norja - EMA (European Medicines Agency)

bial portela & companhia s.a. - opicapone - parkinsonsykdom - anti-parkinson medisiner - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

Norja - norja - Statens legemiddelverk

medical valley invest ab - venlafaksinhydroklorid - depottablett - 150 mg

Norja - norja - Statens legemiddelverk

medical valley invest ab - venlafaksinhydroklorid - depottablett - 75 mg

Norja - norja - Statens legemiddelverk

medical valley invest ab - venlafaksinhydroklorid - depottablett - 225 mg

Norja - norja - Statens legemiddelverk

medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 60 mg

Norja - norja - Statens legemiddelverk

medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 10 mg

Norja - norja - Statens legemiddelverk

medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 18 mg

Norja - norja - Statens legemiddelverk

medice arzneimittel pütter gmbh & co kg - atomoksetinhydroklorid - tablett, filmdrasjert - 25 mg